Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

Journal of Neuroscience Research

Volumn 88, Issue 6, 2010, Pages 1157-1169

  Tan, Michelle G ^a,b   Chua, Wei Ting ^a,c   Esiri, Margaret M ^d   Smith, A David ^d   Vinters, Harry V ^e   Lai, Mitchell K ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Gene expression; Microarray; Neocortex; Neuroinflammation; Neurotransmission; Synapse

Indexed keywords

AQUAPORIN 1; GLUTAMATE DECARBOXYLASE 65; PROTEIN KINASE B; SYNAPSIN; TRANSCRIPTOME;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MICROARRAY ANALYSIS; NEOCORTEX; NEUROTRANSMISSION; NUCLEOTIDE SEQUENCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TEMPORAL CORTEX; UPREGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; MALE; NEOCORTEX; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; TEMPORAL LOBE;

EID: 77951530055     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22290     Document Type: Article

References (66)

1. Abdueva D, Wing MR, Schaub B, Triche TJ. 2007. Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 Gene-Chip arrays. PLoS ONE 2:e913. (Pubitemid 351445309)
2. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. 1988. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50:1914-1923.
3. Bader Lange ML, Cenini G, Piroddi M, Abdul HM, Sultana R, Galli F, Memo M, Butterfield DA. 2008. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease. Neurobiol Dis 29:456-464.
4. Barnes NM, Sharp T. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152. (Pubitemid 29292403)
5. Benjamini Y, Hochberg Y. 2008. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300.
6. Bjartmar L, Huberman AD, Ullian EM, Renteria RC, Liu X, Xu W, Prezioso J, Susman MW, Stellwagen D, Stokes CC, Cho R, Worley P, Malenka RC, Ball S, Peachey NS, Copenhagen D, Chapman B, Nakamoto M, Barres BA, Perin MS. 2006. Neuronal pentraxins mediate synaptic refinement in the developing visual system. J Neurosci 26:6269-6281.
7. Björkdahl C, Sjögren MJ, Zhou X, Concha H, Avila J, Winblad B, Pei JJ. 2008. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. J Neurosci Res 86:1343-1352. (Pubitemid 351571908)
8. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. 2004. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA 101:2173-2178.
9. Blalock EM, Chen KC, Stromberg AJ, Norris CM, Kadish I, Kraner SD, Porter NM, Landfield PW. 2005. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation. Ageing Res Rev 4:481-512. (Pubitemid 43293164)
10. Braak H, Braak E. 1991. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
11. Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA. 2008. Alzheimer disease pathology as a host response. J Neuropathol Exp Neurol 67: 523-531. (Pubitemid 351787079)
12. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. 2002. Gene expression profiling of 12633 genes in Alzheimer hippo-campal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462-473. (Pubitemid 35222383)
13. Cole G, Dobkins KR, Hansen LA, Terry RD, Saitoh T. 1988. Decreased levels of protein kinase C in Alzheimer brain. Brain Res 452:165-174.
14. Cowburn RF, Vestling M, Fowler CJ, Ravid R, Winblad B, O'Neill C. 1993. Disrupted b1-adrenoceptor-G protein coupling in the temporal cortex of patients with Alzheimer's disease. Neurosci Lett 155:163-166. (Pubitemid 23190289)
15. Cross AJ, Crow TJ, Ferrier IN, Johnson JA. 1986. The selectivity of the reduction of serotonin S2 receptors in Alzheimer- type dementia. Neurobiol Aging 7:3-7.
16. Emilsson L, Saetre P, Jazin E. 2006. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling. Neurobiol Dis 21:618-625. (Pubitemid 43277543)
17. Esiri MM, Wilcock GK, Morris JH. 1997. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry 63:749-753. (Pubitemid 27520751)
18. Francis PT, Sims NR, Procter AW, Bowen DM. 1993. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J Neurochem 60:1589-1604.
19. Garcia-Alloza M, Tsang SW, Gil-Bea FJ, Francis PT, Lai MK, Marcos B, Chen CP, Ramirez MJ. 2006. Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol Aging 27:1110-1117. (Pubitemid 43850640)
20. Ghosh AK, Kumaragurubaran N, Hong L, Koelsh G, Tang J. 2008. Memapsin 2 (β-secretase) inhibitors: drug development. Curr Alzheimer Res 5:121-131. (Pubitemid 351536337)
21. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ. 2000. Expression profile of transcripts in Alzheimer's disease tanglebearing CA1 neurons. Ann Neurol 48:77-87.
22. Guan ZZ, Zhang X, Ravid R, Nordberg A. 2000. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243. (Pubitemid 30012774)
23. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356. (Pubitemid 34790756)
24. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y, Yamamoto T, Okada H, Kosaka K, Sakanaka M, Sawada T. 2001. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 284:310-316. (Pubitemid 32917976)
25. Hidalgo J, Penkowa M, Espejo C, Martinez-Caceres EM, Carrasco J, Quintana A, Molinero A, Florit S, Giralt M, Ortega-Aznar A. 2006. Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation. Exp Biol Med 231:1450-1458. (Pubitemid 44547836)
26. Ho GJ, Drego R, Hakimian E, Masliah E. 2005. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 4:247-256. (Pubitemid 40873107)
27. Hope T, Keene J, Fairburn CG, Jacoby R, McShane R. 1999. Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study. Br J Psychiatry 174:39-44. (Pubitemid 29037882)
28. Hwang D, Schmitt WA, Stephanopoulos G, Stephanopoulos G. 2002. Determination of minimum sample size and discriminatory expression patterns in microarray data. Bioinformatics 18:1184-1193.
29. Iqbal K, del C Alonso A, Chen S, Chohan MO, El Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A. 2005. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739:198-210. (Pubitemid 40018538)
30. Kumar U, Patel SC. 2007. Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain. Brain Res 1131:187-196. (Pubitemid 46053892)
31. 2 binding in the cortex. Neurology 57:805-811.
32. Lai MK, Tsang SW, Alder JT, Keene J, Hope T, Esiri MM, Francis PT, Chen CP. 2005. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Psychopharmacology 179:673-677. (Pubitemid 40674769)
33. Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, Herz J, Muglia L, Bu G. 2007. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron 56:66-78. (Pubitemid 47484175)
34. Loring JF, Wen X, Lee JM, Seilhamer J, Somogyi R. 2001. A gene expression profile of Alzheimer's disease. DNA Cell Biol 20:683-695. (Pubitemid 34072835)
35. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. 1998. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150:40-44. (Pubitemid 28146421)
36. Miller JA, Oldham MC, Geshwind DH. 2008. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci 28:1410-1420.
37. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
38. Misawa T, Arima K, Mizusawa H, Satoh JI. 2008. Close association of water channel AQP1 with amyloid-β deposition in Alzheimer disease brains. Acta Neuropathol 116:247-260.
39. Moran LB, Hickey L, Michael GJ, Derkacs M, Christian LM, Kalaitzakis ME, Pearce RK, Graeber MB. 2008. Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies. Acta Neuropathol 115:471-478.
40. Mufson EJ, Counts SE, Ginsberg SD. 2002. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res 27:1035-1048.
41. Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, Matsuoka Y, Ahlijanian M, Lau LF, Duff K. 2003. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38:555-565. (Pubitemid 36645031)
42. Pasinetti GM. 2001. Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 65:471-476.
43. Pérez E, Barrachina M, Rodríguez A, Torrejón- Escribano B, Boada M, Hernández I, Sánchez M, Ferrer I. 2007. Aquaporin expression in the cerebral cortex is increased at early stages of Alzheimer disease. Brain Res 1128:164-174. (Pubitemid 46048625)
44. Perry EK, Gibson PH, Blessed G, Perry RH, Tomlinson BE. 1977. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 34:247-265. (Pubitemid 8188071)
45. Price DL, Sisodia SS. 1998. Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479-505. (Pubitemid 28150671)
46. Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB. 2008. Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 39:1-16.
47. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R. 1986. CAMDEX. A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709. (Pubitemid 17205276)
48. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. 2002. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA 99:4703-4707.
49. Scheff SW, Price DA. 2003. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 24:1029-1046. (Pubitemid 37487881)
50. Selkoe DJ. 2002. Alzheimer's disease is a synaptic failure. Science 298:789-791.
51. Shobab LA, Hsiung GY, Feldman HH. 2005. Cholesterol in Alzheimer's disease. Lancet Neurol 4:841-852.
52. Stockley JH, O'Neill C. 2007. The proteins BACE1 and BACE2 and β-secretase activity in normal and Alzheimer's disease brain. Biochem Soc Trans 35:574-576. (Pubitemid 46975079)
53. Stockley JH, Ravid R, O'Neill C. 2006. Altered β-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain. FEBS Lett 580:6550-6560. (Pubitemid 44827012)
54. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545-15550. (Pubitemid 41528093)
55. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. 1997. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 56:933-944. (Pubitemid 27329114)
56. Tsang SW, Pomakian J, Marshall GA, Vinters HV, Cummings JL, Chen CP, Wong PT, Lai MK. 2007. Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease. Neurobiol Aging 28:1381-1387. (Pubitemid 47081227)
57. Uchikado H, Akiyama H, Kondo H, Ikeda K, Tsuchiya K, Kato M, Oda T, Togo T, Iseki E, Kosaka K. 2004. Activation of vascular endothelial cells and perivascular cells by systemic inflammation - an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol 107:341-351. (Pubitemid 38477361)
58. Walter J, Kaether C, Steiner H, Haass C. 2001. The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr Opin Neurobiol 11:585-590. (Pubitemid 32938290)
59. Warpman U, Alafuzoff I, Nordberg A. 1993. Coupling of muscarinic receptors to GTP proteins in postmortem human brain - alterations in Alzheimer's disease. Neurosci Lett 150:39-43. (Pubitemid 23142321)
60. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239. (Pubitemid 12106486)
61. Wilcock GK, Esiri MM. 1987. Asymmetry of pathology in Alzheimer's disease. J Neurol Neurosurg Psychiatry 50:1384-1386.
62. Williams C, Mehrian SR, Wu Y, Hsu YH, Sitzer T, Spann B, McCleary C, Mo Y, Miller CA. 2009. Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS ONE 4:e4936.
63. Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, Papassotiropoulos A. 2003. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 24:421-426. (Pubitemid 36205049)
64. Wyss-Coray T. 2006. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-1015.
65. Yao PJ, Zhu M, Pyun EI, Brooks AI, Therianos S, Meyers VE, Coleman PD. 2003. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 12:97-109. (Pubitemid 36355860)
66. Zhu X, Lee HG, Raina AK, Perry G, Smith MA. 2002. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11:270-281. (Pubitemid 37494394)